Physician

Sean C Curran, M.D.

According to 2025 Medicare claims, Sean Curran, M.D. (NPI: 1699709071) practices cardiology in the Philadelphia, PA market, with the plurality of this provider's patient population coming from Delaware, PA. This provider's primary affiliated billing organization is BRYN MAWR MEDICAL SPECIALISTS ASSOCIATION (NPI: 1841226099; TIN: 23-1714249) and primary practice location at 19010-3200. Curran is affiliated with the Mass General Brigham ACO, LLC (ACO ID: A4641) and Aledade 101 Regional MSSP (ACO ID: A5216), participating under the MSSP model.

Curran's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,312 traditional Medicare patients, billed 7,686 HCPCS/CPT codes, and received $1,809,594 in Medicare payments. The top billing code was 93306 (Ultrasound of heart with color-depicted blood flow, rate, direction and valve function). Part D data shows 6,994 prescription claims across 830 beneficiaries totaling $1,470,453 in drug costs, led by Xarelto (Rivaroxaban). 2020 DME data shows 24 claims. Open Payments data shows 39 records totaling $829. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $552,528 to $1,809,594. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $420,211 to $1,470,453. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,482	5,786	$552,528
2016	1,481	5,883	$575,467
2017	1,432	6,759	$797,701
2018	1,347	5,864	$949,438
2019	1,420	5,977	$999,163
2020	1,275	5,781	$973,723
2021	1,213	6,058	$1,140,550
2022	1,381	7,077	$1,299,282
2023	1,363	7,036	$1,379,673
2024	1,312	7,686	$1,809,594

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	364	3,977	$420,211
2016	425	4,420	$545,494
2017	492	4,386	$576,784
2018	507	4,463	$662,132
2019	551	4,699	$819,153
2020	570	5,012	$933,536
2021	635	5,146	$1,010,216
2022	699	5,756	$1,040,561
2023	731	6,369	$1,230,112
2024	830	6,994	$1,470,453

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	24	$772
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	447	483	$141
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	463	588	$130
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	579	856	$102
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	444	545	$11
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	434	542	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Xarelto	Rivaroxaban	318	21,464	$392,278
Eliquis	Apixaban	340	19,965	$375,845
Repatha Sureclick	Evolocumab	218	7,356	$140,111
Entresto	Sacubitril/Valsartan	73	5,739	$125,721
Jardiance	Empagliflozin	46	2,940	$54,120

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	39	$829	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Sean C. Curran, M.D.?

Tedicare shows public-source Medicare data for Sean C. Curran, M.D. (NPI 1699709071), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Sean C. Curran, M.D. have ACO affiliation data?

Sean C. Curran, M.D. is shown with ACO affiliation data for Mass General Brigham ACO, LLC (MSSP, ACO ID A4641) and Aledade 101 Regional MSSP (MSSP, ACO ID A5216).

What billing organization is linked to Sean C. Curran, M.D.?

Sean C. Curran, M.D. is linked to BRYN MAWR MEDICAL SPECIALISTS ASSOCIATION (billing NPI 1841226099) in the available physician profile data.

Does Sean C. Curran, M.D. have Open Payments data?

Sean C. Curran, M.D. has 39 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.